Single women must test AMH! Dr. Nathan Zhang from IVF USA discusses IVF-PGT in the United States and Thailand.

2024-01-12 19:06:25，visits： 215

As the age of marriage and childbirth for modern women is delayed, the number of older mothers has significantly increased. The proportion of individuals facing infertility and difficulty conceiving continues to rise, making IVF-PGT an increasingly popular choice, particularly in the United States. However, on the path to realizing the dream of parenthood, a crucial fertility assessment, namely the anti-Müllerian hormone (AMH) test, is often overlooked.

Recently, a 34-year-old single woman approached me through a friend's referral, seeking advice on how to address insomnia in the next 3-5 years after natural pregnancy. She was confident about fertility and even considered egg freezing unnecessary. However, I advised her to undergo an AMH test, and the results surprised her. At the age of 34, her AMH was only 0.62, indicating a probability of less than 30% of conceiving through IVF-PGT, rendering egg freezing almost meaningless. Her best option now is embryo freezing, requiring the use of donor sperm or a sperm bank, and facing the challenge of obtaining a U.S. visa. This is a test and a moment to make wise decisions for her future fertility planning.

For older single women, AMH testing is an indispensable tool for assessing fertility. Issues such as insomnia, hyperthyroidism, and autoimmune diseases can affect ovarian function, increasing the risk of infertility. Similar to considering formaldehyde in home decoration before buying a house, AMH testing before conception can be seen as a necessary "pre-conception check" to ensure the best fertility environment.

Despite the challenges this woman currently faces, her youth is still an advantage. As long as she can come to the U.S., I will personally seek the highest quality medical resources for her because the doctor's experience is crucial on the IVF-PGT journey.

The AMH value plays a crucial role in the assessment of female fertility, with a normal value being greater than 2. Women above 40 find it challenging to reach this level, which is also the reason for their reduced pregnancy rates. Apart from decreased pregnancy rates, women above 40 face greater challenges, including miscarriages and fetal stops, due to declining egg quality. Changes in ovaries and age are irreversible, so women need to maintain physical health at all times, avoiding factors harmful to the ovaries such as smoking, alcohol consumption, and irregular lifestyles.

Currently, AMH testing is one of the most ideal biomarkers in the field of assisted reproduction. Compared to other indicators, AMH value is stable, can be tested on any day of the menstrual cycle, unaffected by the menstrual cycle and hormonal medications, providing an early warning of declining fertility.

We recommend AMH testing for older single women and women who temporarily do not want children after marriage. This test will provide you with intuitive, detailed fertility information, guiding future fertility planning. IVF USA is committed to providing personalized, scientific treatment advice to every patient. Dr. Nathan Zhang, the founder, will personally provide you with professional guidance and support, ensuring a smooth journey through your IVF-PGT. Currently, IVF USA offers services such as egg freezing, IVF-PGT, and third-party assisted reproduction for those in need. The services have expanded beyond the United States to include Japan for IVF-PGT and egg freezing, Thailand for IVF-PGT and egg freezing, as well as Mexico, Taiwan, Hong Kong, and other regions. We collaborate with the world's top IVF doctors to ensure your IVF journey is smooth and unobstructed.